Hills Bank & Trust CO Biogen Inc. Transaction History

Hills Bank & Trust CO

$1.19 Billion
Q2 2024

A detailed history of Hills Bank & Trust CO transactions in Biogen Inc. stock. As of the latest transaction made, Hills Bank & Trust CO holds 4,350 shares of BIIB stock, worth $850,990. This represents 0.08% of its overall portfolio holdings.

Number of Shares

4,350

Previous 4,148 4.87%

Holding current value

$850,990

Previous $894,000 12.75%

% of portfolio

0.08%

Previous 0.08%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 25, 2024	BUY	$190.52 - $236.72 $38,485 - $47,817	202 Added 4.87%	4,350 $1.01 Million
Q1 2024 May 08, 2024	BUY	$212.02 - $267.71 $27,138 - $34,266	128 Added 3.18%	4,148 $894,000
Q4 2023 Feb 07, 2024	BUY	$222.59 - $267.94 $7,345 - $8,842	33 Added 0.83%	4,020 $1.04 Million
Q3 2023 Oct 26, 2023	BUY	$253.3 - $285.89 $82,069 - $92,628	324 Added 8.85%	3,987 $1.02 Million
Q2 2023 Jul 21, 2023	BUY	$275.25 - $318.06 $56,426 - $65,202	205 Added 5.93%	3,663 $1.04 Million
Q1 2023 Apr 17, 2023	BUY	$256.56 - $292.34 $295,813 - $337,068	1,153 Added 50.02%	3,458 $961,000
Q4 2022 Feb 06, 2023	BUY	$252.44 - $306.72 $154,493 - $187,712	612 Added 36.15%	2,305 $639,000
Q3 2022 Nov 03, 2022	BUY	$194.69 - $268.46 $204,813 - $282,419	1,052 Added 164.12%	1,693 $452,000
Q2 2022 Aug 02, 2022	BUY	$187.54 - $223.02 $120,213 - $142,955	641 New	641 $130,000
Q1 2021 May 03, 2021	SELL	$242.95 - $284.63 $109,327 - $128,083	-450 Closed	0 $0
Q4 2020 Feb 01, 2021	SELL	$236.26 - $355.63 $14,411 - $21,693	-61 Reduced 11.94%	450 $110,000
Q3 2020 Oct 27, 2020	SELL	$264.77 - $305.71 $240,675 - $277,890	-909 Reduced 64.01%	511 $145,000
Q2 2020 Aug 05, 2020	SELL	$258.66 - $342.55 $153,902 - $203,817	-595 Reduced 29.53%	1,420 $380,000
Q1 2020 Apr 17, 2020	BUY	$268.85 - $341.04 $20,701 - $26,260	77 Added 3.97%	2,015 $638,000
Q4 2019 Jan 27, 2020	BUY	$220.06 - $304.07 $10,562 - $14,595	48 Added 2.54%	1,938 $575,000
Q3 2019 Oct 18, 2019	BUY	$217.44 - $243.88 $2,174 - $2,438	10 Added 0.53%	1,890 $440,000
Q2 2019 Jul 16, 2019	SELL	$219.29 - $241.72 $683,526 - $753,441	-3,117 Reduced 62.38%	1,880 $439,000
Q1 2019 Apr 17, 2019	BUY	$216.71 - $338.96 $14,302 - $22,371	66 Added 1.34%	4,997 $1.18 Million
Q4 2018 Jan 28, 2019	SELL	$278.5 - $352.75 $13,368 - $16,932	-48 Reduced 0.96%	4,931 $1.48 Million
Q3 2018 Oct 15, 2018	SELL	$293.51 - $383.83 $10,566 - $13,817	-36 Reduced 0.72%	4,979 $1.76 Million
Q2 2018 Jul 17, 2018	BUY	$257.52 - $306.91 $34,250 - $40,819	133 Added 2.72%	5,015 $1.46 Million
Q1 2018 Apr 13, 2018	BUY	$260.13 - $367.91 $19,509 - $27,593	75 Added 1.56%	4,882 $1.34 Million
Q4 2017 Jan 16, 2018	SELL	$307.64 - $344.58 $5,229 - $5,857	-17 Reduced 0.35%	4,807 $1.53 Million
Q3 2017 Oct 16, 2017	BUY	$281.15 - $329.69 $1.36 Million - $1.59 Million	4,824	4,824 $1.51 Million

Others Institutions Holding BIIB

# of Institutions

1,050

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $28.2B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hills Bank & Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Hills Bank & Trust CO with notifications on news.

Account

Hills Bank & Trust CO Biogen Inc. Transaction History